Chiao-Ling Tsai1,2, Wei-Lin Liu3, Feng-Ming Hsu3,2, Po-Sheng Yang4, Ruoh-Fang Yen5,6, Kai-Yuan Tzen5,4, Ann-Lii Cheng3,7,2,8, Pei-Jer Chen1, Jason Chia-Hsien Cheng3,1,7,2. 1. Graduate Institutes of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. 2. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. 3. Graduate Institutes of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. 4. Department of General Surgery, MacKay Memorial Hospital, Taipei, Taiwan. 5. Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan. 6. Molecular Imaging Center, National Taiwan University, Taipei, Taiwan. 7. Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan. 8. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
Several strategies to improve the efficacy of radiation therapy against hepatocellular carcinoma (HCC) have been investigated. One approach is to develop radiosensitizing compounds. Because histone deacetylase 4 (HDAC4) is highly expressed in liver cancer and known to regulate oncogenesis through chromatin structure remodeling and controlling protein access to DNA, we postulated that HDAC4 inhibition might enhance radiation's effect on HCC cells. HCC cell lines (Huh7 and PLC5) and an ectopic xenograft were pretreated with HDAC inhibitor or short hairpin RNA to knock down expression of HDAC4 and then irradiated (2.5-10.0 Gy). We evaluated cell survival by a clonogenic assay; apoptosis by Annexin V immunofluorescence; γH2AX, Rad51, and HDAC4 by immunofluorescence staining; HDAC4, Rad51, and ubiquitin-conjugating enzyme 9 (Ubc9) in HCC cell nuclei by cell fractionation and confocal microscopy; physical interaction between HDAC4/Rad51/Ubc9 by immunoprecipitation; and the downstream targets of HDAC4 knockdown by immunoblotting. Both HDAC4 knockdown and HDAC inhibitor enhanced radiation-induced cell death and reduced homologous recombination repair of DNA double-strand breaks and protein kinase B activation, leading to increased apoptosis. HDAC4 knockdown with or without an HDAC inhibitor significantly delayed tumor growth in a radiation-treated xenograft model. Radiation stimulated nuclear translocation of Rad51 in an HDAC4-dependent manner and the binding of Ubc9 directly to HDAC4, which led to Ubc9 acetylation. Moreover, these effects were accompanied by HDAC4/Ubc9/Rad51 complex dissociation through inhibiting nuclear translocation. Conclusion: HDAC4 signaling blockade enhances radiation-induced lethality in HCC cells and xenografts. These findings raise the possibility that HDAC4/Ubc9/Rad51 complex in DNA repair may be a target for radiosensitization of HCC. (Hepatology 2018;67:586-599).
Several strategies to improve the efficacy of radiation therapy against hepatocellular carcinoma (HCC) have been investigated. One approach is to develop radiosensitizing compounds. Because histone deacetylase 4 (HDAC4) is highly expressed in liver cancer and known to regulate oncogenesis through chromatin structure remodeling and controlling protein access to DNA, we postulated that HDAC4 inhibition might enhance radiation's effect on HCC cells. HCC cell lines (Huh7 and PLC5) and an ectopic xenograft were pretreated with HDAC inhibitor or short hairpin RNA to knock down expression of HDAC4 and then irradiated (2.5-10.0 Gy). We evaluated cell survival by a clonogenic assay; apoptosis by Annexin V immunofluorescence; γH2AX, Rad51, and HDAC4 by immunofluorescence staining; HDAC4, Rad51, and ubiquitin-conjugating enzyme 9 (Ubc9) in HCC cell nuclei by cell fractionation and confocal microscopy; physical interaction between HDAC4/Rad51/Ubc9 by immunoprecipitation; and the downstream targets of HDAC4 knockdown by immunoblotting. Both HDAC4 knockdown and HDAC inhibitor enhanced radiation-induced cell death and reduced homologous recombination repair of DNA double-strand breaks and protein kinase B activation, leading to increased apoptosis. HDAC4 knockdown with or without an HDAC inhibitor significantly delayed tumor growth in a radiation-treated xenograft model. Radiation stimulated nuclear translocation of Rad51 in an HDAC4-dependent manner and the binding of Ubc9 directly to HDAC4, which led to Ubc9 acetylation. Moreover, these effects were accompanied by HDAC4/Ubc9/Rad51 complex dissociation through inhibiting nuclear translocation. Conclusion:HDAC4 signaling blockade enhances radiation-induced lethality in HCC cells and xenografts. These findings raise the possibility that HDAC4/Ubc9/Rad51 complex in DNA repair may be a target for radiosensitization of HCC. (Hepatology 2018;67:586-599).
Authors: Maxwell T Laws; Robin E Bonomi; Swatabdi Kamal; David J Gelovani; Jeremy Llaniguez; Shreya Potukutchi; Xin Lu; Thomas Mangner; Juri G Gelovani Journal: Sci Rep Date: 2019-03-05 Impact factor: 4.379
Authors: Kim Freese; Tatjana Seitz; Peter Dietrich; Serene M L Lee; Wolfgang E Thasler; Anja Bosserhoff; Claus Hellerbrand Journal: Cancers (Basel) Date: 2019-10-18 Impact factor: 6.639
Authors: Lin Zhao; Xiangying Deng; Yueshuo Li; Jianmin Hu; Longlong Xie; Feng Shi; Min Tang; Ann M Bode; Xin Zhang; Weihua Liao; Ya Cao Journal: EMBO Mol Med Date: 2021-11-09 Impact factor: 12.137